Discover 1 curated intelligence briefings related to this specific topic.
As GLP-1 receptor agonists redefine weight management, a critical blind spot has emerged: the loss of lean muscle mass. From clinical settings in Europe to wellness hubs in Asia, the medical community is pivoting from simple weight reduction to a sophisticated strategy of precision protein nutrition and resistance training to prevent sarcopenia.
